According to the report, the global plasma fractionation market is expected to generate around $36.8 bn by 2025, at a CAGR of around 7.2% between 2019 and 2025.

SARASOTA, FLORIDA, UNITED STATES, September 15, 2022 /EINPresswire.com/ -- Zion Market Research has published a new report titled “Global Plasma Fractionation Market by Product (Albumin, Protease Inhibitors, Coagulation Factor Concentrates, Immunoglobulins, and Others), by Application (Immunology, Hematology, Neurology, Rheumatology, Pulmonology, and Others), and by End-User (Hospitals & Clinics, Clinical Research Laboratories, Medical and Academic Institutes, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018 –2025”.

𝐀𝐜𝐜𝐨𝐫𝐝𝐢𝐧𝐠 𝐭𝐨 𝐭𝐡𝐞 𝐫𝐞𝐩𝐨𝐫𝐭, 𝐭𝐡𝐞 𝐠𝐥𝐨𝐛𝐚𝐥 𝐩𝐥𝐚𝐬𝐦𝐚 𝐟𝐫𝐚𝐜𝐭𝐢𝐨𝐧𝐚𝐭𝐢𝐨𝐧 𝐦𝐚𝐫𝐤𝐞𝐭 𝐰𝐚𝐬 𝐚𝐩𝐩𝐫𝐨𝐱𝐢𝐦𝐚𝐭𝐞𝐥𝐲 𝐔𝐒𝐃 𝟐𝟐.𝟔 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐢𝐧 𝟐𝟎𝟏𝟖 𝐚𝐧𝐝 𝐢𝐬 𝐞𝐱𝐩𝐞𝐜𝐭𝐞𝐝 𝐭𝐨 𝐠𝐞𝐧𝐞𝐫𝐚𝐭𝐞 𝐚𝐫𝐨𝐮𝐧𝐝 𝐔𝐒𝐃 𝟑𝟔.𝟖 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 𝟐𝟎𝟐𝟓, 𝐚𝐭 𝐚 𝐂𝐀𝐆𝐑 𝐨𝐟 𝐚𝐫𝐨𝐮𝐧𝐝 𝟕.𝟐% 𝐛𝐞𝐭𝐰𝐞𝐞𝐧 𝟐𝟎𝟏𝟗 𝐚𝐧𝐝 𝟐𝟎𝟐𝟓.

Plasma processing is a process to obtain pure components that can be further used for injection and transfusion. The Cohn process (also called cold ethanol fractionation) was developed by Edwin J. Cohn during World War II, which was a major breakthrough in the field of blood plasma fractionation. Plasma proteins have biomarkers that help in the detection of rare diseases.

This serves many clinical purposes. Plasma contains an innumerable variety of proteins. Around 20 of these proteins serve to produce plasma products, which are used to cure severe plasma conditions.

𝐁𝐫𝐨𝐰𝐬𝐞 𝐭𝐡𝐫𝐨𝐮𝐠𝐡 𝟓𝟒 𝐓𝐚𝐛𝐥𝐞𝐬 & 𝟑𝟐 𝐅𝐢𝐠𝐮𝐫𝐞𝐬 𝐬𝐩𝐫𝐞𝐚𝐝 𝐨𝐯𝐞𝐫 𝟏𝟏𝟎 𝐏𝐚𝐠𝐞𝐬 𝐚𝐧𝐝 𝐢𝐧-𝐝𝐞𝐩𝐭𝐡 𝐓𝐎𝐂 𝐨𝐧 “𝐆𝐥𝐨𝐛𝐚𝐥 𝐏𝐥𝐚𝐬𝐦𝐚 𝐅𝐫𝐚𝐜𝐭𝐢𝐨𝐧𝐚𝐭𝐢𝐨𝐧 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐢𝐳𝐞 & 𝐒𝐡𝐚𝐫𝐞 𝟐𝟎𝟐𝟐: 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐓𝐫𝐞𝐧𝐝𝐬, 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐬, 𝐌𝐚𝐫𝐤𝐞𝐭 𝐏𝐥𝐚𝐲𝐞𝐫𝐬, 𝐆𝐫𝐨𝐰𝐭𝐡, 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬, 𝐚𝐧𝐝 𝐅𝐨𝐫𝐞𝐜𝐚𝐬𝐭 𝐭𝐨 𝟐𝟎𝟐𝟖”.

𝐓𝐨 𝐤𝐧𝐨𝐰 𝐚𝐛𝐨𝐮𝐭 𝐭𝐡𝐞 𝐨𝐭𝐡𝐞𝐫 𝐝𝐫𝐢𝐯𝐞𝐫𝐬 & 𝐜𝐡𝐚𝐥𝐥𝐞𝐧𝐠𝐞𝐬 - 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐚 𝐬𝐚𝐦𝐩𝐥𝐞 𝐧𝐨𝐰!

The increased penetration of the global plasma fractionation market is largely due to the increased use of immunoglobulins and alpha-1-antitrypsin in areas of medicine and the consistent investments in medicine and R&D, which have resulted in cost-effective procedures. The global population has a significant proportion of aged people, who suffer from rare diseases that often require high plasma proteins.

There are multiple centers to collect plasma that facilitates smooth treatment and also the subsequent development of the plasma fractionation market globally.

There has been huge government support for increasing awareness and availability of plasma-derived medicine products for therapeutic usage. Purification methods and chromatographic fractionation have been used for plasma fractionation, which has resulted in the development of plasma products, such as coagulation factors, protease inhibitors, albumin, and immunoglobulin. However, the affordability of plasma products may be a major concern for patients worldwide.

𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧

The plasma fractionation market is fragmented on the basis of product, application, and end-user. Based on product, the market is segmented into protease inhibitors, albumin, coagulation factor concentrates (factor IX, prothrombin complex concentrate, factor VIII, Von Willebrand factor, factor XIII, and fibrinogen concentrates), and immunoglobulins (subcutaneous immunoglobulin, intravenous immunoglobulin (IVIG), and other immunoglobulins), and others.

The application segment is divided into immunology, hematology, neurology, rheumatology, pulmonology, and others. The end-user segment comprises clinical research laboratories, hospitals and clinics, medical and academic institutes, and others.

𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐅𝐫𝐞𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐏𝐃𝐅 𝐁𝐫𝐨𝐜𝐡𝐮𝐫𝐞: https://www.zionmarketresearch.com/requestbrochure/plasma-fractionation-market

North America leads the extraction of plasma proteins and treatment of genetic and blood-related disorders, which makes it the global leader of the plasma fractionation market. This is due to the increasing use of immunoglobulin in neurological and autoimmune diseases and prophylaxis treatments. Increasing IgG demand is the key driver fuelling the fractionation technology in the region.

There are advancements in processes, improved formulations, and increased production efficiency. Advanced technology concepts, such as protein separation technology and continuous centrifugation, are used to improve the process of plasma manufacturing. There are many clinics across the region for targeted gene therapies with new advancements in treatments related to cardiovascular diseases, cancer immunotherapies, and blood-related disorders.

The European market is the second-most largely developed region for plasma fractionation. The growing incidences of blood-related disorders and rising aging population base are stimulating the European plasma fractionation market.

Countries like the UK, France, and Germany have huge potential and have established several companies aiding the research and developments in this area, such as Octapharma, Bio Products Laboratory, Biotest, Ares Genetics, Syndesi Therapeutics, and Galecto Biotech.

Browse the full “𝐏𝐥𝐚𝐬𝐦𝐚 𝐅𝐫𝐚𝐜𝐭𝐢𝐨𝐧𝐚𝐭𝐢𝐨𝐧 𝐌𝐚𝐫𝐤𝐞𝐭 𝐛𝐲 𝐏𝐫𝐨𝐝𝐮𝐜𝐭 (𝐀𝐥𝐛𝐮𝐦𝐢𝐧, 𝐏𝐫𝐨𝐭𝐞𝐚𝐬𝐞 𝐈𝐧𝐡𝐢𝐛𝐢𝐭𝐨𝐫𝐬, 𝐂𝐨𝐚𝐠𝐮𝐥𝐚𝐭𝐢𝐨𝐧 𝐅𝐚𝐜𝐭𝐨𝐫 𝐂𝐨𝐧𝐜𝐞𝐧𝐭𝐫𝐚𝐭𝐞𝐬, 𝐈𝐦𝐦𝐮𝐧𝐨𝐠𝐥𝐨𝐛𝐮𝐥𝐢𝐧𝐬, 𝐚𝐧𝐝 𝐎𝐭𝐡𝐞𝐫𝐬), 𝐛𝐲 𝐀𝐩𝐩𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧 (𝐈𝐦𝐦𝐮𝐧𝐨𝐥𝐨𝐠𝐲, 𝐇𝐞𝐦𝐚𝐭𝐨𝐥𝐨𝐠𝐲, 𝐍𝐞𝐮𝐫𝐨𝐥𝐨𝐠𝐲, 𝐑𝐡𝐞𝐮𝐦𝐚𝐭𝐨𝐥𝐨𝐠𝐲, 𝐏𝐮𝐥𝐦𝐨𝐧𝐨𝐥𝐨𝐠𝐲, 𝐚𝐧𝐝 𝐎𝐭𝐡𝐞𝐫𝐬), 𝐚𝐧𝐝 𝐛𝐲 𝐄𝐧𝐝-𝐔𝐬𝐞𝐫 (𝐇𝐨𝐬𝐩𝐢𝐭𝐚𝐥𝐬 & 𝐂𝐥𝐢𝐧𝐢𝐜𝐬, 𝐂𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐋𝐚𝐛𝐨𝐫𝐚𝐭𝐨𝐫𝐢𝐞𝐬, 𝐌𝐞𝐝𝐢𝐜𝐚𝐥 𝐚𝐧𝐝 𝐀𝐜𝐚𝐝𝐞𝐦𝐢𝐜 𝐈𝐧𝐬𝐭𝐢𝐭𝐮𝐭𝐞𝐬, 𝐚𝐧𝐝 𝐎𝐭𝐡𝐞𝐫𝐬): 𝐆𝐥𝐨𝐛𝐚𝐥 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐏𝐞𝐫𝐬𝐩𝐞𝐜𝐭𝐢𝐯𝐞, 𝐂𝐨𝐦𝐩𝐫𝐞𝐡𝐞𝐧𝐬𝐢𝐯𝐞 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬, 𝐚𝐧𝐝 𝐅𝐨𝐫𝐞𝐜𝐚𝐬𝐭, 𝟐𝟎𝟏𝟖 –𝟐𝟎𝟐𝟓” Report at https://www.zionmarketresearch.com/report/plasma-fractionation-market

The Asia Pacific region exhibits the highest potential to grow notably in the global plasma fractionation market in the years ahead. Increased disposable income, rising lifestyle-related disorders, growing healthcare expenditure, and escalating awareness about health disorders are driving the region’s plasma fractionation market.

Additionally, the increasing aging population and cancer prevalence are further driving the plasma fractionation market in the Asia Pacific region. In most countries like India, Japan, and China, domestic plasma collection from domestic sources is still mostly controlled by government or government-designated National Blood Centers and national Red Cross organizations. They have small plasma fractionation facilities that can fractionate thousands of liters of plasma annually.

The Middle East and Africa represent an underdeveloped regional plasma fractionation market and are projected to grow at a slow pace over the forecast time period.

The Latin American plasma fractionation market witnessed a moderate growth over the past years and is considered an emerging market for plasma fractionation. It is projected to exhibit considerable growth in the plasma fractionation market in the upcoming years.

𝐈𝐧𝐪𝐮𝐢𝐫𝐞 𝐦𝐨𝐫𝐞 𝐚𝐛𝐨𝐮𝐭 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐛𝐞𝐟𝐨𝐫𝐞 𝐩𝐮𝐫𝐜𝐡𝐚𝐬𝐢𝐧𝐠 @ https://www.zionmarketresearch.com/inquiry/plasma-fractionation-market

𝐒𝐨𝐦𝐞 𝐤𝐞𝐲 𝐩𝐥𝐚𝐲𝐞𝐫𝐬 𝐨𝐩𝐞𝐫𝐚𝐭𝐢𝐧𝐠 𝐢𝐧 𝐭𝐡𝐞 𝐠𝐥𝐨𝐛𝐚𝐥 𝐩𝐥𝐚𝐬𝐦𝐚 𝐟𝐫𝐚𝐜𝐭𝐢𝐨𝐧𝐚𝐭𝐢𝐨𝐧 𝐦𝐚𝐫𝐤𝐞𝐭 𝐚𝐫𝐞

-CSL
-BPL
-LFB
-Biotest
-Kedrion
-Green Cross
-Octapharma
-Japan Blood Products
-China Biologic Products
-Shanghai RAAS Blood

𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐜𝐮𝐬𝐭𝐨𝐦𝐢𝐳𝐞𝐝 𝐜𝐨𝐩𝐲 𝐨𝐟 𝐫𝐞𝐩𝐨𝐫𝐭 @ https://www.zionmarketresearch.com/custom/1277

FREQUENTLY ASKED QUESTIONS
1)Which key factors will influence Plasma Fractionation Market growth over 2022-2028?
2)What will be the value of the Plasma Fractionation Market during 2022-2028?
3)Which are the key major players in Plasma Fractionation Market growth?
4)Which region will contribute notably towards the fast-food market value?

𝐏𝐡𝐚𝐫𝐦𝐚𝐜𝐞𝐮𝐭𝐢𝐜𝐚𝐥 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐑𝐞𝐩𝐨𝐫𝐭𝐬 - https://www.zionmarketresearch.com/category/pharmaceutical

𝐑𝐞𝐥𝐚𝐭𝐞𝐝 𝐑𝐞𝐩𝐨𝐫𝐭𝐬:

Plasma Fractionation Market- https://www.globenewswire.com/news-release/2019/07/05/1878769/0/en/Global-Plasma-Fractionation-Market-Will-Reach-USD-36-8-Billion-By-2025-Zion-Market-Research.html

Gastrointestinal Bleeding Treatment Market - https://www.zionmarketresearch.com/report/gastrointestinal-bleeding-treatment-market

Generic Oncology Drugs Market - https://www.zionmarketresearch.com/report/generic-oncology-drugs-market

Bicomponent Fiber Market- https://www.zionmarketresearch.com/report/bicomponent-fiber-market

Empty Capsules Market - https://www.zionmarketresearch.com/report/empty-capsules-market

https://www.zionmarketresearch.com/report/overactive-bladder-treatment-market

Overactive Bladder Treatment Market

Kavita More
Zion Market Research
+1 855-465-4651
Kavita.m@marketresearchstore.com
Visit us on social media:
Facebook
Twitter
LinkedIn
Other

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.